Clinical Trial: Imipenem/Cilastatin vs. Standard Therapy for Complicated Intra-Abdominal Infections at High Risk of CRE: A Single-Center Prospective Cohort Study (China)

Posted On: 2026-08-11

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Imipenem/Cilastatin vs. Standard Therapy for Complicated Intra-Abdominal Infections at High Risk of CRE: A Single-Center Prospective Cohort Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129787

Registration Time: 2026/08/10

Type: Observational study

Primary Sponsor: Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336177

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Imipenem/Cilastatin vs. Standard Therapy for Complicated Intra-Abdominal Infections at High Risk of CRE: A Single-Center Prospective Cohort Study (China)